CN108852856A - Application of the Epigallo-catechin gallate (EGCG) in orthodontic art - Google Patents
Application of the Epigallo-catechin gallate (EGCG) in orthodontic art Download PDFInfo
- Publication number
- CN108852856A CN108852856A CN201810943521.9A CN201810943521A CN108852856A CN 108852856 A CN108852856 A CN 108852856A CN 201810943521 A CN201810943521 A CN 201810943521A CN 108852856 A CN108852856 A CN 108852856A
- Authority
- CN
- China
- Prior art keywords
- epigallo
- egcg
- art
- orthodontic
- catechin gallate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 title claims abstract description 19
- 229940030275 epigallocatechin gallate Drugs 0.000 title claims abstract description 19
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 title claims abstract description 18
- 210000003298 dental enamel Anatomy 0.000 claims abstract description 13
- 208000008617 Tooth Demineralization Diseases 0.000 claims abstract description 3
- 206010072665 Tooth demineralisation Diseases 0.000 claims abstract description 3
- 239000000470 constituent Substances 0.000 claims abstract 2
- 239000011230 binding agent Substances 0.000 claims description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims 1
- 244000080767 Areca catechu Species 0.000 claims 1
- 235000006226 Areca catechu Nutrition 0.000 claims 1
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims 1
- 239000000853 adhesive Substances 0.000 abstract description 10
- 230000001070 adhesive effect Effects 0.000 abstract description 10
- 230000001580 bacterial effect Effects 0.000 abstract description 4
- 238000012937 correction Methods 0.000 abstract description 2
- 239000007767 bonding agent Substances 0.000 abstract 1
- 230000007406 plaque accumulation Effects 0.000 abstract 1
- 238000005115 demineralization Methods 0.000 description 17
- 230000002328 demineralizing effect Effects 0.000 description 17
- 208000002741 leukoplakia Diseases 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 229920005989 resin Polymers 0.000 description 6
- 239000011347 resin Substances 0.000 description 6
- 239000002253 acid Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 208000002925 dental caries Diseases 0.000 description 3
- 238000005530 etching Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 241000519995 Stachys sylvatica Species 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000001680 brushing effect Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000194019 Streptococcus mutans Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010044029 Tooth deposit Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000004840 adhesive resin Substances 0.000 description 1
- 229920006223 adhesive resin Polymers 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 201000010840 enamel caries Diseases 0.000 description 1
- -1 epigallocatechin gallate Ester Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/60—Preparations for dentistry comprising organic or organo-metallic additives
- A61K6/69—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/30—Compositions for temporarily or permanently fixing teeth or palates, e.g. primers for dental adhesives
Landscapes
- Health & Medical Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
技术领域technical field
本发明涉及医药技术领域,尤其是一种表没食子儿茶素没食子酸酯在牙齿正畸术中的应用。The invention relates to the technical field of medicine, in particular to the application of epigallocatechin gallate in orthodontics.
背景技术Background technique
白斑(White spot lesion, WSL)是传统固定矫正常见的副作用,发病率为2%-96%,男性大于女性。白斑一般发生在唇面托槽周围,尤其表现为釉质表面细小的白色线条,严重时可伴发龋坏。白斑的微观表现是釉质脱矿,其发展迅速,在口腔卫生差的情况下,仅四周就可以观察到釉质表面脱矿,形成白斑。在传统正畸治疗过程中,需要在牙齿唇面粘接托槽。粘接托槽后,牙齿自洁作用降低,刷牙难度增大,托槽周围容易附着菌斑。以上原因都会导致牙齿表面细菌数量增多,尤其是变形链球菌和乳酸杆菌。这些细菌产酸导致釉质表面pH下降,发生脱矿,严重时会伴发牙齿表面龋坏。白斑产生的牙齿颜色改变会影响正畸术后效果,带来口腔美学问题,并且在正畸矫正器拆除后难以恢复。White spot lesion (WSL) is a common side effect of traditional fixed correction, with an incidence rate of 2%-96%, and men are more than women. Leukoplakia generally occurs around the lip brackets, especially as fine white lines on the surface of the enamel, and may be accompanied by caries in severe cases. The microscopic manifestation of leukoplakia is enamel demineralization, which develops rapidly, and in the case of poor oral hygiene, demineralization of the enamel surface can be observed in only four weeks to form leukoplakia. During traditional orthodontic treatment, brackets need to be bonded to the labial surface of the teeth. After bonding the brackets, the self-cleaning effect of the teeth is reduced, the difficulty of brushing teeth is increased, and plaque is easy to adhere around the brackets. The above reasons will lead to an increase in the number of bacteria on the tooth surface, especially Streptococcus mutans and Lactobacillus. The acid production of these bacteria leads to a decrease in the pH of the enamel surface, demineralization, and in severe cases, caries on the tooth surface. The change in tooth color caused by leukoplakia can affect the effect of orthodontic surgery, cause oral aesthetic problems, and it is difficult to recover after orthodontic appliances are removed.
从带环粘接到托槽粘接,正畸经历了革命性的发展,不同的粘接剂、粘接底板设计、酸蚀方法、粘接材料不断被研究、发展。目前,临床釉质粘接主要采用全酸蚀粘接系统。通过37%的磷酸酸蚀,在牙釉质表面形成凹坑状结构,其与树脂形成的微机械锁结提供粘接力。为了预防白斑的产生,目前,临床上采用的处理白斑的方法主要有预防方法主要有口腔卫生宣教,使用各种含氟产品、氯己定,控制酸蚀时间,应用含抗菌材料的树脂、玻璃离子改良的树脂粘接剂等。然而,个人口腔护理、使用含氟产品需要患者配合,使用含抗菌材料的树脂、玻璃离子改良的树脂粘接剂有一定临床效果,但白斑仍然是临床上常见的正畸并发症之一。因此,探索更有效的药物和预防方法仍然是现阶段的研究方向之一。From band bonding to bracket bonding, orthodontics has experienced revolutionary development. Different adhesives, bonding base designs, acid etching methods, and bonding materials have been continuously researched and developed. At present, the clinical enamel bonding mainly adopts the full-etch bonding system. Through 37% phosphoric acid etching, a pit-like structure is formed on the surface of the enamel, and the micromechanical lock formed with the resin provides adhesion. In order to prevent the occurrence of leukoplakia, at present, the methods used clinically to deal with leukoplakia mainly include preventive methods, mainly including oral hygiene education, using various fluorine-containing products, chlorhexidine, controlling acid etching time, and applying resin and glass containing antibacterial materials. Ion-improved resin adhesives, etc. However, personal oral care and the use of fluorine-containing products require the cooperation of patients. The use of resins containing antibacterial materials and glass ionomer-modified resin adhesives has certain clinical effects, but leukoplakia is still one of the common clinical orthodontic complications. Therefore, exploring more effective drugs and prevention methods is still one of the current research directions.
发明内容Contents of the invention
本发明所要解决的问题是提供一种表没食子儿茶素没食子酸酯在牙齿正畸术中的应用方案,这种应用方案能够有效降低临床正畸患者托槽周围脱矿、白斑的发生率。The problem to be solved by the present invention is to provide an application scheme of epigallocatechin gallate in orthodontics, which can effectively reduce the incidence of demineralization and leukoplakia around brackets in clinical orthodontic patients.
为了解决上述技术问题,本发明所采用的技术方案是:将表没食子儿茶素没食子酸酯作为防止牙齿脱矿作用的活性成分添加到牙齿正畸术中使用的托槽的釉质粘结剂中。In order to solve the above-mentioned technical problems, the technical solution adopted in the present invention is: adding epigallocatechin gallate as an active ingredient to prevent tooth demineralization into the enamel binder of the bracket used in orthodontics .
本发明的表没食子儿茶素没食子酸酯,是从绿茶中提取出的一种多酚类单体,具有抗菌、抗氧化、抗炎以及抗肿瘤等作用,且生物毒性低;它并不能直接杀死细菌,而是抑制了细菌脱氢酶活性,从而抑制细菌产酸过程,减少牙齿表面pH降低,达到防止釉质表面脱矿及龋坏的发生。Epigallocatechin gallate of the present invention is a kind of polyphenolic monomer extracted from green tea, has antibacterial, anti-oxidation, anti-inflammatory and anti-tumor effects, and low biological toxicity; it cannot directly Instead of killing bacteria, it inhibits the activity of bacterial dehydrogenase, thereby inhibiting the process of bacterial acid production, reducing the pH drop on the tooth surface, and preventing the demineralization of the enamel surface and the occurrence of caries.
由于采用了本发明技术方案,与现有技术相比,具有的有益效果是:本发明在牙齿正畸术中将表没食子儿茶素没食子酸酯添加到托槽所使用的粘接剂中,能够有效减少固定矫正患者托槽周围菌斑堆积以及降低白斑发生率。Due to the adoption of the technical solution of the present invention, compared with the prior art, the beneficial effect is: the present invention adds epigallocatechin gallate to the adhesive used in brackets in orthodontics, It can effectively reduce the accumulation of bacterial plaque around the brackets of fixed orthodontic patients and reduce the incidence of leukoplakia.
具体实施方式Detailed ways
以下结合具体实施例对本发明作进一步详述,但本发明的技术范围不受这些实施例限定。The present invention will be further described below in conjunction with specific examples, but the technical scope of the present invention is not limited by these examples.
患者选择:选择50位志愿者,根据随机原则将志愿者分为左半口实验组、右半口对照组或右半口实验组、左半口对照组,形成自身对照。Patient selection: 50 volunteers were selected, and according to the random principle, the volunteers were divided into left-half-mouth experimental group, right-half-mouth control group or right-half-mouth experimental group and left-half-mouth control group to form self-control.
试验方法:配制含2mg/ml的表没食子儿茶素没食子酸酯的粘接剂,实验组在粘接托槽过程中使用该粘接剂,对照组则使用不含表没食子儿茶素没食子酸酯的同一品牌粘接剂。实验开始前,对每位志愿者进行龈上洁治,去除口内牙结石等,将菌斑指数调整至同一基线。根据分组情况为每一位志愿者粘接托槽,粘接托槽时,注意刮净托槽周围多余树脂。除是否添加表没食子儿茶素没食子酸酯外,托槽品牌、粘接树脂、粘接剂等因素需完全一致,且所有步骤由同一位医生操作。托槽粘接完成后,对每位患者进行口腔卫生宣教,告知患者使用Bass刷牙法,以及分发统一品牌的牙刷牙膏。Test method: prepare an adhesive containing 2mg/ml epigallocatechin gallate, the experimental group uses the adhesive in the process of bonding brackets, and the control group uses no epigallocatechin gallate Ester adhesive of the same brand. Before the start of the experiment, supragingival cleaning was performed on each volunteer to remove dental calculus in the mouth, etc., and the plaque index was adjusted to the same baseline. According to the grouping situation, the brackets were bonded for each volunteer. When bonding the brackets, pay attention to scraping off the excess resin around the brackets. Except for the addition of epigallocatechin gallate, factors such as bracket brand, adhesive resin, and adhesive must be completely consistent, and all steps should be performed by the same doctor. After the bracket bonding was completed, oral hygiene education was given to each patient, and the patients were told to use the Bass method of brushing teeth, and a uniform brand of toothbrush and toothpaste was distributed.
检查方法和结果:Check method and result:
采用Quigley-Hein改良的Turesky菌斑指数判定前牙区菌斑指数和脱矿指数。在检查前去除患者口内弓丝和附件,嘱患者漱口,吹干,并根据下列标准进行记录:The Quigley-Hein modified Turesky plaque index was used to determine the plaque index and demineralization index of the anterior teeth. Remove the arch wire and accessories in the patient's mouth before the examination, instruct the patient to rinse and dry, and record according to the following criteria:
(1)脱矿指数:(1) Demineralization index:
0: 无脱矿,未见釉质龋白斑;0: no demineralization, no enamel caries leukoplakia;
1:轻度脱矿,可见白色脱矿区域,但釉质表面结构无破坏;1: Mild demineralization, white demineralized areas can be seen, but the surface structure of the enamel is not damaged;
2:中度脱矿,可见白色脱矿区域,且釉质表面粗糙,但不需要修复治疗;2: Moderate demineralization, white demineralized areas can be seen, and the enamel surface is rough, but no restorative treatment is required;
3:重度脱矿,可见白色脱矿区且釉质破坏,需要修复治疗;3: Severe demineralization, white demineralized areas can be seen and the enamel is damaged, and repair treatment is required;
4:龋洞。4: Cavities.
(2)菌斑指数:(2) Plaque index:
0:无菌斑;0: no plaque;
1:牙龈缘存在不连续的菌斑;1: There is discontinuous plaque on the gingival margin;
2:牙龈缘存在小于1mm的连续的菌斑;2: There is continuous plaque less than 1mm in the gingival margin;
3:牙面存在大于1mm但小于1/3 牙面的连续菌斑;3: There are continuous plaques larger than 1 mm but less than 1/3 of the tooth surface;
4:菌斑面积超过1/3但小于2/3;4: The plaque area exceeds 1/3 but less than 2/3;
5:菌斑面积超过2/3。5: The plaque area exceeds 2/3.
分别在4周、3个月、6个月、12个月时间段检查患者菌斑指数以及脱矿指数进行记录,结果见表1-表4: The plaque index and demineralization index of patients were checked and recorded at 4 weeks, 3 months, 6 months, and 12 months. The results are shown in Table 1-Table 4:
表1:菌斑及脱矿指数记录表(4周,平均值)Table 1: Plaque and demineralization index recording table (4 weeks, average value)
表2:菌斑及脱矿指数记录表(3个月,平均值)Table 2: Plaque and demineralization index recording table (3 months, average value)
表3:菌斑及脱矿指数记录表(6个月,平均值)Table 3: Plaque and demineralization index recording table (6 months, average value)
表4:菌斑及脱矿指数记录表(12个月,平均值)Table 4: Plaque and demineralization index recording table (12 months, average value)
由表1-表4的对比试验可以看出,比较实验组和对照组菌斑指数和脱矿指数具有显著差异。得出结论,在牙齿正畸术中,将表没食子儿茶素没食子酸酯添加到托槽使用的粘接剂中,能够有效减少固定矫正患者托槽周围菌斑堆积以及降低白斑发生率。As can be seen from the comparative tests in Table 1-Table 4, there are significant differences in plaque index and demineralization index between the experimental group and the control group. It is concluded that in orthodontics, adding epigallocatechin gallate to the adhesive used in brackets can effectively reduce the accumulation of plaque around the brackets and reduce the incidence of white spots in patients with fixed orthodontics.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810943521.9A CN108852856A (en) | 2018-08-17 | 2018-08-17 | Application of the Epigallo-catechin gallate (EGCG) in orthodontic art |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810943521.9A CN108852856A (en) | 2018-08-17 | 2018-08-17 | Application of the Epigallo-catechin gallate (EGCG) in orthodontic art |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108852856A true CN108852856A (en) | 2018-11-23 |
Family
ID=64318227
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810943521.9A Pending CN108852856A (en) | 2018-08-17 | 2018-08-17 | Application of the Epigallo-catechin gallate (EGCG) in orthodontic art |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108852856A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116747143A (en) * | 2023-07-21 | 2023-09-15 | 首都医科大学附属北京口腔医院 | Application of L-arginine in the preparation of orthodontic bonding compositions |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101674797A (en) * | 2007-05-31 | 2010-03-17 | 学校法人日本大学 | Adhesive for teeth-straightening members |
CN101938985A (en) * | 2008-02-08 | 2011-01-05 | 高露洁-棕榄公司 | Compositions and devices |
CN105342863A (en) * | 2015-12-11 | 2016-02-24 | 张凌 | Application of epigallocatechingallate (EGCG) in improving dental resin adhesive material restoration performance |
CN105658633A (en) * | 2013-09-03 | 2016-06-08 | 新加坡科技研究局 | Polymer-flavonoid conjugates and hydrogels for biomedical applications |
-
2018
- 2018-08-17 CN CN201810943521.9A patent/CN108852856A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101674797A (en) * | 2007-05-31 | 2010-03-17 | 学校法人日本大学 | Adhesive for teeth-straightening members |
CN101938985A (en) * | 2008-02-08 | 2011-01-05 | 高露洁-棕榄公司 | Compositions and devices |
CN105658633A (en) * | 2013-09-03 | 2016-06-08 | 新加坡科技研究局 | Polymer-flavonoid conjugates and hydrogels for biomedical applications |
CN105342863A (en) * | 2015-12-11 | 2016-02-24 | 张凌 | Application of epigallocatechingallate (EGCG) in improving dental resin adhesive material restoration performance |
Non-Patent Citations (6)
Title |
---|
(美)格莱伯等: "《正畸治疗中的风险管理》", 31 October 2010, 人民军医出版社 * |
JIEQIONG HU等: "《Antibacterial and physical properties of EGCG-containing glass ionomer cements》", 《JOURNAL OF DENTISTRY》 * |
XIJIN DU等: "《Epigallocatechin-3-gallate (EGCG) enhances the therapeutic》", 《JOURNAL OF DENTISTRY》 * |
左艳萍等: "《实用口腔正畸矫治方法与技巧》", 28 February 2017, 科学技术文献出版 * |
张丁: "《口腔正畸学的临床基础》", 29 February 2000, 中国医药科技出版社 * |
林永旺等: "《表没食子儿茶素浸食子酸酯对脱矿釉质再矿化作用的体外研究》", 《牙体牙髓牙周病学杂志》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116747143A (en) * | 2023-07-21 | 2023-09-15 | 首都医科大学附属北京口腔医院 | Application of L-arginine in the preparation of orthodontic bonding compositions |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Loguercio et al. | A 36-month evaluation of self-etch and etch-and-rinse adhesives in noncarious cervical lesions | |
US5403577A (en) | Dental composition for hypersensitive teeth | |
CN110996891B (en) | Gel comprising chlorhexidine | |
Zabokova-Bilbilova et al. | White spot lesions: prevention and management during the orthodontic treatment | |
US20050175959A1 (en) | System for the controlled delivery of an active material to a dental site | |
US20130108982A1 (en) | Reshapable Device for Fixation at a Dental Site | |
US9668844B2 (en) | Device for fixation at a dental site | |
JP2002537003A (en) | Dispensing system for oral care substances using a permanently deformable piece of material | |
Okida et al. | The use of fragments of thin veneers as a restorative therapy for anterior teeth disharmony: a case report with 3 years of follow-up | |
TW201125489A (en) | Biofilm disruptive compositions | |
Izgi et al. | Direct restorative treatment of peg-shaped maxillary lateral incisors with resin composite: a clinical report | |
Lowder et al. | Bond strength of 4 orthodontic adhesives used with a caries-protective resin sealant | |
Shim et al. | Antiplaque and antigingivitis effects of a mouthrinse containing cetylpyridinium chloride, triclosan and dipotassium glycyrrhizinate | |
Scott et al. | An update in adult orthodontics | |
JP6381912B2 (en) | Oral composition | |
Metin-Gürsoy et al. | The relationship between orthodontic treatment and dental caries | |
JP2020514354A5 (en) | ||
Giuca et al. | Oral manifestations in paediatric patients with hepatobiliary diseases: A review | |
Laing et al. | An update on oral hygiene products and techniques | |
CN108852856A (en) | Application of the Epigallo-catechin gallate (EGCG) in orthodontic art | |
JPH1149625A (en) | Artificial tooth stabilizing agent composition | |
JPS59225109A (en) | Composition for oral cavity application | |
Farzin et al. | The effect of two types of denture adhesive on the satisfaction parameters of complete denture wearers | |
US20140271499A1 (en) | Article and method of initiating bone regrowth and restoration of gum recession with localized subgingival delivery of medications | |
Isaeva et al. | Efficacy of a Plant-Based Dental Gel for Chronic Simple Marginal Gingivitis: A Clinical Trial |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181123 |